Metraipolis › archive › dc_77fd95c0a1ea
PrP turnover in vivo and the time to effect of prion disease therapeutics — Europe PMC PMID:42189860
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42189860
- DOI
- 10.1371/journal.ppat.1014263
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-01T07:01:39.940Z
- SHA-256 of the archived text
447c042bdc302175468bcfd80bcf510eadd4c167403bb1d9f7dc8c2c9c9e1637- Stable URL of this page
https://metraipolis.com/documento/dc_77fd95c0a1ea
How to cite
PrP turnover in vivo and the time to effect of prion disease therapeutics — Europe PMC PMID:42189860 — Europe PMC (en), https://europepmc.org/article/MED/42189860 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_77fd95c0a1ea (Metraipolis archive dc_77fd95c0a1ea, sha256 447c042bdc302175468bcfd80bcf510eadd4c167403bb1d9f7dc8c2c9c9e1637)
BibTeX
@misc{dc77fd95c0a1ea,
title = {PrP turnover in vivo and the time to effect of prion disease therapeutics — Europe PMC PMID:42189860},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42189860},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_77fd95c0a1ea; sha256 447c042bdc302175468bcfd80bcf510eadd4c167403bb1d9f7dc8c2c9c9e1637},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42189860. Agents can read the archived copy with the MCP tool read_document.